Item 4.01. Changes in Registrant's Certifying Accountant.
--------------------------------------------------------------------------------
On July 22, 2021, the Audit Committee of the Board of Directors (the "Audit
Committee") of MJ Biotech Inc, (the "Company") approved the engagement of WWC,
Professional Corporation ("WWC, P.C.") as the Company's new independent
registered public accounting firm for the years ending December 31, 2019, and
December 31, 2020. The change will be effective upon WWC, P.C. completion of its
standard client acceptance process and execution of an engagement letter. The
previous auditor Fruci & Associates II PLLC (F&A II PLLC) resigned as the
Company's independent registered public accounting firm on July 21, 2020.
During the years ended December 31, 2018 and 2017, and the subsequent interim
period from January 31, 2018 through June 30, 2018, there were no (1)
disagreements (as defined in Item 304(a)(1)(iv) of Regulation S-K and related
instructions) with F&A II PLLC on any matter of accounting principles or
practices, financial statement disclosure, or auditing scope or procedure, which
disagreements, if not resolved to the satisfaction of F&A II PLLC, would have
caused F&A II PLLC to make reference to the subject matter of the disagreement
in their reports, or (2) reportable events (as defined in Item 304(a)(1)(v) of
Regulation S-K).
The audit reports of F&A II PLLC on the Company's consolidated financial
statements as of and for the years ended December 31, 2018, and 2017, did not
contain any adverse opinion or disclaimer of opinion, nor were they qualified or
modified as to uncertainty, audit scope or accounting principles.
The Company has provided F&A II PLLC with a copy of the disclosures it is making
in this Current Report on Form 8-K prior to its filing with the Securities and
Exchange Commission ("SEC") and has requested F&A II PLLC to furnish the Company
with a letter addressed to the SEC stating whether or not it agrees with the
statements made herein, and if not, stating the reasons for their
disagreement. Attached as Exhibit 99.01 is a copy of the letter of F&A II PLLC.
During the years ended December 31, 2018 and 2017, and the subsequent interim
period through March 31, 2019, neither the Company nor anyone on its behalf has
consulted F&A II PLLC with respect to either (i) the application of accounting
principles to a specified transaction, either completed or proposed, or the type
of audit opinion that might be rendered on the Company's consolidated financial
statements or the effectiveness of internal control over financial reporting,
where either a written report or oral advice was provided to the Company that
F&A II PLLC concluded was an important factor considered by the Company in
reaching a decision as to any accounting, auditing or financial reporting issue;
or (ii) any matter that was either the subject of a disagreement (as defined in
Item 304(a)(1)(iv) of Regulation S-K and related instructions) or a reportable
event (as defined in Item 304(a)(1)(v) of Regulation S-K).
© Edgar Online, source Glimpses